413 related articles for article (PubMed ID: 28717093)
1. Paraneoplastic Anti-3-hydroxy-3-methylglutary-coenzyme A Reductase Antibody-positive Immune-mediated Necrotizing Myopathy in a Patient with Uterine Cancer.
Mizuma A; Kouchi M; Netsu S; Yutani S; Kitao R; Suzuki S; Murata K; Nagata E; Takizawa S
Intern Med; 2017; 56(14):1915-1918. PubMed ID: 28717093
[TBL] [Abstract][Full Text] [Related]
2. [A case of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibody-positive paraneoplastic necrotizing myopathy associated with advanced gastric cancer that responded to intravenous immunoglobulin therapy].
Yamaguchi T; Matsunaga A; Ikawa M; Shirafuji N; Nishino I; Hamano T
Rinsho Shinkeigaku; 2017 Mar; 57(3):118-123. PubMed ID: 28228619
[TBL] [Abstract][Full Text] [Related]
3. [Dermatomyositis-like syndrome revealing statin-induced necrotizing autoimmune myopathy with anti-HMGCR antibodies].
Merlant M; Fite C; Kottler D; Maisonobe L; Dossier A; Deschamps L; Descamps V
Ann Dermatol Venereol; 2019 Sep; 146(8-9):550-556. PubMed ID: 30929872
[TBL] [Abstract][Full Text] [Related]
4. Immune-mediated myopathy related to anti 3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies as an emerging cause of necrotizing myopathy induced by statins.
Lahaye C; Beaufrére AM; Boyer O; Drouot L; Soubrier M; Tournadre A
Joint Bone Spine; 2014 Jan; 81(1):79-82. PubMed ID: 23953224
[TBL] [Abstract][Full Text] [Related]
5. Influenza A (H3N2) infection followed by anti-signal recognition particle antibody-positive necrotizing myopathy: A case report.
Iriki J; Yamamoto K; Senju H; Nagaoka A; Yoshida M; Iwasaki K; Ashizawa N; Hirayama T; Tashiro M; Takazono T; Imamura Y; Miyazaki T; Izumikawa K; Yanagihara K; Tsujino A; Fukuoka J; Uetani M; Satoh M; Mukae H
Int J Infect Dis; 2021 Feb; 103():33-36. PubMed ID: 33217572
[TBL] [Abstract][Full Text] [Related]
6. Pathogenic role of anti-signal recognition protein and anti-3-Hydroxy-3-methylglutaryl-CoA reductase antibodies in necrotizing myopathies: Myofiber atrophy and impairment of muscle regeneration in necrotizing autoimmune myopathies.
Arouche-Delaperche L; Allenbach Y; Amelin D; Preusse C; Mouly V; Mauhin W; Tchoupou GD; Drouot L; Boyer O; Stenzel W; Butler-Browne G; Benveniste O
Ann Neurol; 2017 Apr; 81(4):538-548. PubMed ID: 28224701
[TBL] [Abstract][Full Text] [Related]
7. [Screening of autoantibodies associated with necrotizing myopathy among undiagnosed chronic myopathy].
Kuru S; Suzuki S; Ogata K; Kobayashi M; Ishida C; Watanabe C; Matsumura T
Rinsho Shinkeigaku; 2017 Oct; 57(10):562-566. PubMed ID: 28954975
[TBL] [Abstract][Full Text] [Related]
8. Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy.
Watanabe Y; Uruha A; Suzuki S; Nakahara J; Hamanaka K; Takayama K; Suzuki N; Nishino I
J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1038-44. PubMed ID: 27147697
[TBL] [Abstract][Full Text] [Related]
9. Belimumab for Immune-Mediated Necrotizing Myopathy Associated With Anti-SRP Antibodies: A Case Report and Retrospective Review of Patients Treated With Anti-B-Cell Therapy in a Single Center and Literature.
Cui BB; Tian YR; Ma XY; Yin G; Xie Q
Front Immunol; 2021; 12():777502. PubMed ID: 34925350
[TBL] [Abstract][Full Text] [Related]
10. Necrosis in anti-SRP
Allenbach Y; Arouche-Delaperche L; Preusse C; Radbruch H; Butler-Browne G; Champtiaux N; Mariampillai K; Rigolet A; Hufnagl P; Zerbe N; Amelin D; Maisonobe T; Louis-Leonard S; Duyckaerts C; Eymard B; Goebel HH; Bergua C; Drouot L; Boyer O; Benveniste O; Stenzel W
Neurology; 2018 Feb; 90(6):e507-e517. PubMed ID: 29330311
[TBL] [Abstract][Full Text] [Related]
11. [Childhood-onset anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase (anti-HMGCR) necrotizing myopathy needs to be distinguished from muscular dystrophy: A case study].
Hama Y; Mori-Yoshimura M; Komaki H; Suzuki S; Kohsaka H; Nishino I; Takahashi Y
Rinsho Shinkeigaku; 2017 Oct; 57(10):567-572. PubMed ID: 28966227
[TBL] [Abstract][Full Text] [Related]
12. Statin-naïve anti-HMGCR antibody-mediated necrotizing myopathy in China.
Jiao Y; Cai S; Lin J; Zhu W; Xi J; Li J; Yue D; Zhang T; Qiao K; Wang Y; Zhao C; Lu J
J Clin Neurosci; 2018 Nov; 57():13-19. PubMed ID: 30205933
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous involvement in anti-HMGCR positive necrotizing myopathy.
Williams B; Horn MP; Banz Y; Feldmeyer L; Villiger PM
J Autoimmun; 2021 Sep; 123():102691. PubMed ID: 34332436
[TBL] [Abstract][Full Text] [Related]
14. Increasing incidence of immune-mediated necrotizing myopathy: single-centre experience.
Klein M; Mann H; Pleštilová L; Zámečník J; Betteridge Z; McHugh N; Vencovský J
Rheumatology (Oxford); 2015 Nov; 54(11):2010-4. PubMed ID: 26109604
[TBL] [Abstract][Full Text] [Related]
15. [Anti-HMG-CoA reductase necrotizing myopathy: A report of 4 cases].
Marti J; Kolev I; Lorleac'h A; Besnard S; Pihan M; Marcorelles P
Rev Med Interne; 2017 Apr; 38(4):228-234. PubMed ID: 27876175
[TBL] [Abstract][Full Text] [Related]
16. Immune-mediated necrotizing myopathy: clinical features and pathogenesis.
Allenbach Y; Benveniste O; Stenzel W; Boyer O
Nat Rev Rheumatol; 2020 Dec; 16(12):689-701. PubMed ID: 33093664
[TBL] [Abstract][Full Text] [Related]
17. Immune-mediated necrotizing myopathy due to statins exposure.
Villa L; Lerario A; Calloni S; Peverelli L; Matinato C; DE Liso F; Ceriotti F; Tironi R; Sciacco M; Moggio M; Triulzi F; Cinnante C
Acta Myol; 2018 Dec; 37(4):257-262. PubMed ID: 30944904
[TBL] [Abstract][Full Text] [Related]
18. Immune-Mediated Necrotizing Myopathy.
Pinal-Fernandez I; Casal-Dominguez M; Mammen AL
Curr Rheumatol Rep; 2018 Mar; 20(4):21. PubMed ID: 29582188
[TBL] [Abstract][Full Text] [Related]
19. Spectrum of immune-mediated necrotizing myopathies and their treatments.
Pinal-Fernandez I; Mammen AL
Curr Opin Rheumatol; 2016 Nov; 28(6):619-24. PubMed ID: 27607340
[TBL] [Abstract][Full Text] [Related]
20. Concurrent positive anti-3-hydroxy-3-methylglutaryl-coenzyme a reductase antibody with reducing body myopathy: Possible double trouble.
Tanboon J; Sanmaneechai O; Charuvanij S; Sangruchi T; Galindo-Feria AS; Lundberg IE; Ohnuki Y; Shiina T; Suzuki S; Nishino I
Neuromuscul Disord; 2019 Jul; 29(7):543-548. PubMed ID: 31204143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
